SLC1A3 and Alzheimer disease: A postmortem study showed increases in EAAT1 levels in a subset of pyramidal neurons exhibiting degeneration in the AD brain (139), whereas another postmortem study and in vitro assay showed impaired function of EAAT2 in the AD brain (140).